Caris Life Sciences ® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today announced ...

AI-driven genomic analysis could help researchers identify existing drugs that may be repurposed for subtype-specific breast ...

An artificial intelligence-based tool may help physicians determine which newly diagnosed multiple myeloma patients are most likely to benefit from specific therapies, including immunotherapy and stem ...

You will be redirected to our submission process. Non-communicable diseases (NCDs), including cardiovascular disease, cancer, diabetes, chronic respiratory conditions, and neurological disorders, ...